Source: Eur Respir J 2003 Oct 01;22(4):596-601
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Springer J., Fischer A.. Substance P-induced pulmonary vascular remodelling in precision cut lung slices. Eur Respir J 2003 Oct 01;22(4):596-601

Member's Comments

No comment yet.

Related content which might interest you: Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 Inhibition of the Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition Source: Eur Respir J 2008; 31: 599-610 Year: 2008 Apoptosis and cell proliferation in chronic hypoxic pulmonary hypertension Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms Year: 2007 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2011; 37: 1104-1118 Year: 2011 In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Source: Eur Respir J 2011; 38: 789-796 Year: 2011 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Inflammation in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 358-363 Year: 2003 Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Role of anti-proliferative therapy in PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Interstitial pressure and lung oedema in chronic hypoxia Source: Eur Respir J 2011; 37: 943-949 Year: 2011 Serotonin transporter genes, pulmonary haemodynamics and pulmonary hypertension Source: Annual Congress 2005 - Scientific year in review Year: 2005 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 LPS and TNFa differentially increase intrapulmonary airway and artery contraction in mouse precision cut lung slices Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018